{"id":"W4414813522","doi":"10.1007/s10120-025-01660-4","title":"Comparative efficacy and safety of tislelizumab and other programmed cell death protein 1 inhibitors in first-line treatment of advanced gastroesophageal cancers: a systematic review and network meta-analysis","year":2025,"lang":"en","type":"review","venue":"Gastric Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Pembrolizumab; Nivolumab; Chemotherapy; Programmed cell death 1; Adverse effect; Incidence (geometry); Surgical oncology; Gastroesophageal Junction","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003815503,0.0006341002,0.01014649,0.0004000776,0.00004544613,0.00001290991,0.00008887127,0.000151815,0.00007486308],"category_scores_gemma":[0.00002599845,0.0004023349,0.0009504655,0.001832126,0.0001633756,0.0000350056,0.00004515752,0.0001624002,1.487157e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000599646,"about_ca_system_score_gemma":0.0005509511,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001351642,"about_ca_topic_score_gemma":0.001146758,"domain_scores_codex":[0.9967074,0.0003279419,0.001739043,0.0006193324,0.0002614791,0.0003447657],"domain_scores_gemma":[0.9977205,0.0002837855,0.001334716,0.0004431418,0.000100524,0.0001172811],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0008413302,0.0002700374,0.0001104332,0.8281017,0.06829306,0.00001200321,0.0002360348,0.00004394482,0.00000123215,0.000002146869,0.00003581833,0.1020522],"study_design_scores_gemma":[0.006165662,0.00181375,0.0001152227,0.2917283,0.6801607,0.00003338411,0.00004593508,0.00002034243,0.00001177902,0.000001599462,0.01951832,0.0003850477],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001720143,0.9871331,0.00002616458,0.00004794819,0.00002630392,0.01216542,0.0003818796,0.00001163481,0.00003557611],"genre_scores_gemma":[0.001109748,0.9940825,0.000596319,0.00004515035,0.00003615503,0.003720429,0.00005231526,0.00002826834,0.0003291847],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6118676,"threshold_uncertainty_score":0.9998428,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06392817142680882,"score_gpt":0.3591512268560754,"score_spread":0.2952230554292666,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}